dapivirine
Jump to navigation
Jump to search
Indications
- preexposure prophylaxis for HIV1 delivered in a vaginal ring*
* 56% efficacy among women > 21 years if age but no protection i in those < 21 years
- difference could be explained by poor adherence among younger women
Mechanism of action
More general terms
References
- ↑ Baeten JM, Palanee-Phillips T, Brown ER et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med 2016 Feb 22 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26900902 Free full text <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1506110